← Contracts
PT
Ajuste direto para aquisição de T1140 - TRIPTORRELINA (PÓ P/ SOL INJ) [0.1 MG/ML; 1 ML; FRS] e T202 - TRIPTORRELINA (PÓ P/ SUSP INJ) [3,75MG; FRS/ SERINGA] para suprir necessidades na área da saúde.
ID 12662899
· Portal BASE
Price
Base Price
€18,450
.00
Effective Price
€3,733
.00
-79.8%
Contract Details
- Contract Type
- Aquisição de bens móveis
- Procedure
- Ajuste Direto Regime Geral
- CPV Code
- 33600000
- Location
- Portugal, Lisboa, Lisboa
- Bidder Count
- —
Winner
IPSEN PORTUGAL - PRODUTOS FARMACEUTICOS S.A.
NIF 502609800
Dates
- Publication
- 19 Jan 2026
- Celebration
- 23 Dec 2025
Contracting Entity
Centro Hospitalar Universitário Lisboa Central, EPE
NIF 508080142
Public body
Data Source
Portal BASE
Api
· synced 2026-04-17
Risk Flags
Score 50 · MEDIUM RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
- Publication Date
- 19 Jan 2026
- Signing Date
- 23 Dec 2025
- Days Late
- 27
- Rule
- A2/A3 late publication: 27 days after signing (threshold: 10)
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
- Base price
- 18450.0
- Total effective price
- 3733.0
- Ratio
- 0.2023
- Direction
- reduction
- Rule
- A9 price reduction: ratio 0.2023 outside [0.5, 1.5]
Detected 2026-03-06